Public Health Trace

Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters

Drug Recall Terminated Historical recordClass II

Fluorescein/Indocyanine, Lyophilized (P.F.), 400 mg/15 mg, 1 mL, Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

DMSO (Dimethyl Sulfoxide) with Lidocaine 50%/0.5% mL Solution, 50 mL bottle, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate 24 mg/mL (2.4%), Injectable, 2 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Dexamethasone Sodium Phosphate 200 mg/mL, Injectable, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin+B12(C), Lyophilized, 10,000 unit + 40 mcg Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin Lyophilized, 20,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin, Lyophilized, 7,500 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin, Lyophilized, 6,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin, Lyophilized, 5,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin, Lyophilized, 3,500 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin (New York State), 11,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Ceftazidime, Lyophilized, Ophthalmic 2.25% Kit, Rx only, Compounded by Wells Pharmacy, Ocala , FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Carnitine-L 250 mg/mL Injectable, 30 mL vials, Rx only, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Bimix 30 mg/1 mg/mL Injectable, a) 5 mL and b) 10 mL vial, Compounded by Wells Pharmacy Network, LLC, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

B-complex + Vit C 20 mg/mL Injectable, 30 mL vial, Compounded by Wells Pharmacy Network, LLC, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Arginine/Citrulline/Ornit+Lido 100/100/100/10 mg/mL Injectable, 10 mL vials, Compounded by Wells Pharmacy Network, LLC, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Arginine HCl 100 mg/mL Injectable,10 mL, Compounded by Wells Pharmacy Network, LLC, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Alprostadil 40 mcg/mL Injectable, 10 mL vials, Compounded by Wells Pharmacy Network LLC, Ocala FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

Chorionic Gonadotropin, Lyophilized (HCG) 11,000 Unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Drug Recall Terminated Historical recordClass II

ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 200 mg/mL, 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL

by Wells Pharmacy Network LLC

Reason: Lack of Assurance of Sterility
Recall initiated: September 21, 2016
Reported by FDA: January 11, 2017
Distribution: Nationwide

View recall →

Data last updated: September 25, 2026 ET

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.